Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2275

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1A
Chunk 2275
---
 check companies unfavorably and might use these powers, or threaten to use these powers, to hinder
the sale of securities of blank check companies in their states. Further, if our securities were no longer listed on Nasdaq, our securities
would not be covered securities and we would be subject to regulation in each state in which we offer our securities.

If,
after listing, we fail to satisfy the continued listing requirements of Nasdaq such as the corporate governance requirements or the minimum
closing bid price requirement, Nasdaq may take steps to delist its securities. Such a delisting would likely have a negative effect on
the price of the securities and would impair your ability to sell or purchase the securities when you wish to do so. In the event of
a delisting, we can provide no assurance that any action taken by it to restore compliance with listing requirements would allow its
securities to become listed again, stabilize the market price or improve the liquidity of its securities, prevent its securities from
dropping below the Nasdaq minimum bid price requirement or prevent future non-compliance with Nasdaq’s listing requirements. Additionally,
if our securities are not listed on, or become delisted from, Nasdaq for any reason, and are quoted on any of the markets offered by
OTC Markets Group Inc., the liquidity and price of these securities may be more limited than if they were quoted or listed on Nasdaq
or another national securities exchange. Our securityholders may be unable to sell their securities unless a market can be established
or sustained.

An
active market for our securities may not develop, which would adversely affect the liquidity and price our securities.

The
price of our securities may vary significantly due to factors specific to us as well as to general market or economic conditions. Furthermore,
an active trading market for our securities may never develop or, if developed, it may not be sustained. Holders of our securities may
be unable to sell their securities unless a market can be established and sustained.

The
market price of our securities may decline as a result market factors.

Fluctuations
in the price of our securities could contribute to the loss of all or part of your investment. If an active market for our securities
develops and continues, the trading price of our securities could be volatile and subject to wide fluctuations in response to various
factors, some of which are beyond our control. Any of the factors listed below could have a material adverse effect on your investment
in our securities and our securities may trade at prices significantly below